| 7.59 0.33 (4.55%) | 09-20 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 9.79 |
1-year : | 11.15 |
| Resists | First : | 8.38 |
Second : | 9.55 |
| Pivot price | 8.07  |
|||
| Supports | First : | 6.5 |
Second : | 5.4 |
| MAs | MA(5) : | 8.08 |
MA(20) : | 8.04 |
| MA(100) : | 8.97 |
MA(250) : | 8.55 |
|
| MACD | MACD : | 0.1 |
Signal : | 0.1 |
| %K %D | K(14,3) : | 47.1 |
D(3) : | 54.4 |
| RSI | RSI(14): 46 |
|||
| 52-week | High : | 44.56 | Low : | 3.69 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ MEDS ] has closed below the lower bollinger band by 13.5%. Although price has broken the lower band and a downside breakout is possible; the most likely direction for [ MEDS ] is to continue within current trading range. It is unclear right now based on current values. 84.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 68 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 8.42 - 8.47 | 8.47 - 8.51 |
| Low: | 7.42 - 7.48 | 7.48 - 7.52 |
| Close: | 7.46 - 7.55 | 7.55 - 7.61 |
TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. It operates the TRxADE drug procurement marketplace, which fosters price transparency and serves approximately 11,800 members; and offers patient centric telehealth services under the Bonum Health brand name. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. is based in Land O' Lakes, Florida.
Tue, 24 Sep 2024
TRxADE Health changes its name to Scienture Holdings - AlphaStreet
Tue, 24 Sep 2024
TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc. and Ticker Symbol Change to “SCNX” - StockTitan
Fri, 20 Sep 2024
TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc. - StockTitan
Fri, 26 Jul 2024
Trxade Health closes business combination with Scienture in $103Mln deal - AlphaStreet
Fri, 26 Jul 2024
TRxADE Health, Inc. Announces Business Combination with Scienture, Inc., in a Transaction Valued at $103 Million - StockTitan
Fri, 28 Jun 2024
MEDS Earnings: Highlights of Trxade Health’s Q1 2024 financial results - AlphaStreet
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Pharmaceuticals
|
|
| Shares Out | 0 (M) |
| Shares Float | 2 (M) |
| Held by Insiders | 734540 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 43 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -1.204e+007 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 56.6 % |
| Operating Margin | -7 % |
| Return on Assets (ttm) | 998.7 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 7.45e+006 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 4.44 |
| EBITDA (p.s.) | -6.83 |
| Qtrly Earnings Growth | -24.4 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -7 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 1.69 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 15000 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|